Cargando…
The Wedelolactone Derivative Inhibits Estrogen Receptor-Mediated Breast, Endometrial, and Ovarian Cancer Cells Growth
Estrogen and estrogen receptor (ER)-mediated signaling pathways play important roles in the etiology and progression of human breast, endometrial, and ovarian cancers. Attenuating ER activities by natural products and their derivatives is a relatively practical strategy to control and reduce breast,...
Autores principales: | Xu, Defeng, Lin, Tzu-Hua, Yeh, Chiuan-Ren, Cheng, Max A., Chen, Lu-Min, Chang, Chawnshang, Yeh, Shuyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157183/ https://www.ncbi.nlm.nih.gov/pubmed/25221777 http://dx.doi.org/10.1155/2014/713263 |
Ejemplares similares
-
Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor β-DAB2IP signals
por: Yeh, Chiuan-Ren, et al.
Publicado: (2015) -
Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ERβ/CCL2/CCR2 EMT/MMP9 signals
por: Rao, Qun, et al.
Publicado: (2015) -
Estrogen Receptor Alpha Prevents Bladder Cancer Development via INPP4B inhibited Akt Pathway in vitro and in vivo
por: Hsu, Iawen, et al.
Publicado: (2014) -
The potential role of herbal extract Wedelolactone for treating particle-induced osteolysis: an in vivo study
por: Lu, Yung-Chang, et al.
Publicado: (2022) -
Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer
por: Shang, Zhiqun, et al.
Publicado: (2016)